122 related articles for article (PubMed ID: 6643007)
1. The correlation between estrogen receptor status, axillary-node metastases and disease-free interval after surgery in primary breast cancer.
Caldarola L; Calderini P; Volterrani P; Di Carlo F; Gaglia P
Ital J Surg Sci; 1983; 13(3):179-85. PubMed ID: 6643007
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
4. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptors and breast cancer: prognostic and therapeutic implications.
Gapinski PV; Donegan WL
Surgery; 1980 Sep; 88(3):386-93. PubMed ID: 7414516
[TBL] [Abstract][Full Text] [Related]
6. Node-negative breast cancer treated by modified radical mastectomy without adjuvant therapies: variables associated with disease recurrence and survivorship.
Huseby RA; Ownby HE; Frederick J; Brooks S; Russo J; Brennan MJ
J Clin Oncol; 1988 Jan; 6(1):83-8. PubMed ID: 3335894
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of subcutaneous mastectomy with radical mastectomy.
Horiguchi J; Iino JHY ; Takei H; Koibuchi Y; Iijima K; Ikeda F; Ochiai R; Uchida K; Yoshida M; Yokoe T; Morishita Y
Anticancer Res; 2001; 21(4B):2963-7. PubMed ID: 11712794
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor determination and long term survival of patients with carcinoma of the breast.
Crowe JP; Gordon NH; Hubay CA; Shenk RR; Zollinger RM; Brumberg DJ; McGuire WL; Shuck JM
Surg Gynecol Obstet; 1991 Oct; 173(4):273-8. PubMed ID: 1925896
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading.
Parl FF; Schmidt BP; Dupont WD; Wagner RK
Cancer; 1984 Nov; 54(10):2237-42. PubMed ID: 6488142
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor status as a prognostic indicator for stage I breast cancer patients.
Crowe JP; Hubay CA; Pearson OH; Marshall JS; Rosenblatt J; Mansour EG; Hermann RE; Jones JC; Flynn WJ; McGuire WL
Breast Cancer Res Treat; 1982; 2(2):171-6. PubMed ID: 7171837
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics.
Carreño G; Del Casar JM; Corte MD; González LO; Bongera M; Merino AM; Juan G; Obregón R; Martínez E; Vizoso FJ
Breast Cancer Res Treat; 2007 Mar; 102(1):61-73. PubMed ID: 16850244
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: effect on prognosis and survival.
Bulte JP; van Wely BJ; Kasper S; Kuijt G; van den Wildenberg FJ; Strobbe LJ; de Wilt JH
Breast Cancer Res Treat; 2013 Jul; 140(1):143-9. PubMed ID: 23793602
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer.
Skinner JR; Wanebo HJ; Betsill WL; Wilhelm MC; Drake CR; Macleod RM
Ann Surg; 1982 Dec; 196(6):636-41. PubMed ID: 7149814
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
[TBL] [Abstract][Full Text] [Related]
16. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
17. The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery.
Kiba T; Inamoto T; Nishimura T; Ueno M; Yanagihara K; Teramukai S; Kato H; Toi M; Fukushima M
BMC Cancer; 2008 Nov; 8():323. PubMed ID: 18990247
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status.
Yang PS; Chen CM; Liu MC; Jian JM; Horng CF; Liu MJ; Yu BL; Lee MY; Chi CW
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):516-22. PubMed ID: 19577858
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor protein of breast cancer in patients with positive nodes. High recurrence rates in the postmenopausal estrogen receptor-negative group.
Kinne DW; Butler JA; Kimmel M; Flehinger BJ; Menendez-Botet C; Schwartz M
Arch Surg; 1987 Nov; 122(11):1303-6. PubMed ID: 3675194
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
